semaglutide cardiovascular outcomes news today 2025 and in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial Study Finds Oral Semaglutide Vastly

Our mission is to help you embrace these changes with confidence

71,72 From a clinical perspective, these conflicting data suggest that motility-related adverse events are uncommon but may occur in susceptible individuals, particularly with prolonged exposure or in the presence of pre-existing GI motility disorders

This can enhance adherence to treatment, as some patients may be reluctant to use injectable medications due to needle phobia or convenience factors

The International Journal of Artificial Organs

L-Carnitine and CLA are both supplements that may have benefits for weight loss and athletic performance, but they work through different mechanisms

Novo Nordisk monthly prices as benchmark (Figure 2): India: 94277 USD/month reduced to 60175 USD/month after generic entry (Economic Times, March 31, 2026) U.S.: 1,0281,349 USD/month (upper range), 350 USD/month (most favored nation price) Auto-injector pens dominate Indias generic entries Auto-injector pens have emerged as the dominant dosage form for generic semaglutide, with 11 out of 13 companies choosing this format (Figure 3) : 11 companies have launched auto-injector pens (Abbott, Alkem Laboratories, Dr